Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation.
Wils LJ, Buijze M, Stigter-van Walsum M, Brink A, van Kempen BE, Peferoen L, Brouns ER, de Visscher JGAM, van der Meij EH, Bloemena E, Poell JB, Brakenhoff RH. Wils LJ, et al. Among authors: stigter van walsum m. Cells. 2024 Apr 19;13(8):710. doi: 10.3390/cells13080710. Cells. 2024. PMID: 38667326 Free PMC article.
Intratumor genetic heterogeneity and head and neck cancer relapse.
Pierik AS, Poell JB, Brink A, Stigter-van Walsum M, de Roest RH, Poli T, Yaromin A, Lambin P, Leemans CR, Brakenhoff RH. Pierik AS, et al. Among authors: stigter van walsum m. Radiother Oncol. 2024 Feb;191:110087. doi: 10.1016/j.radonc.2024.110087. Epub 2024 Jan 6. Radiother Oncol. 2024. PMID: 38185257 Free article.
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.
de Boer DV, Martens-de Kemp SR, Buijze M, Stigter-van Walsum M, Bloemena E, Dietrich R, Leemans CR, van Beusechem VW, Braakhuis BJM, Brakenhoff RH. de Boer DV, et al. Among authors: stigter van walsum m. Oncotarget. 2017 May 16;8(58):97928-97940. doi: 10.18632/oncotarget.17880. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228663 Free PMC article.
An Antibody-Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy.
Bakema JE, Stigter-van Walsum M, Harris JR, Ganzevles SH, Muthuswamy A, Houtkamp M, Plantinga TS, Bloemena E, Brakenhoff RH, Breij ECW, van de Ven R. Bakema JE, et al. Among authors: stigter van walsum m. Mol Cancer Ther. 2024 Feb 1;23(2):187-198. doi: 10.1158/1535-7163.MCT-23-0298. Mol Cancer Ther. 2024. PMID: 37828725
39 results